✦ LIBER ✦

Re: Mammalian Target of Rapamycin (mTOR) Regulates Cellular Proliferation and Tumor Growth in Urothelial Carcinoma

✍ Scribed by Wood, David P.

Book ID: 118483289
Publisher: Lippincott Williams and Wilkins
Year: 2011
Tongue: English
Weight: 52 KB
Volume: 186
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2011.03.097

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Hypoxia-Inducible Factor and Mammali

Re: Hypoxia-Inducible Factor and Mammalian Target of Rapamycin Pathway Markers in Urothelial Carcinoma of the Bladder: Possible Therapeutic Implications

✍ Wood, David P. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 105 KB

MP77-04 MULTI-INSTITUTIONAL EVALUATION O

MP77-04 MULTI-INSTITUTIONAL EVALUATION OF THE PROGNOSTIC SIGNIFICANCE OF ALTERED MAMMALIAN TARGET OF RAPAMYCIN (MTOR) PATHWAY BIOMARKERS IN UPPER TRACT UROTHELIAL CARCINOMA (UTUC)

✍ Bagrodia, Aditya; Krabbe, Laura; Gayed, Bishoy; Kapur, Payal; Darwish, Oussama; 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 162 KB

A comprehensive immunohistochemical and

A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma

✍ Korkolopoulou, Penelope; Levidou, Georgia; Trigka, Eleni-Andriana; Prekete, Niki 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 718 KB

Comparative efficacy of vascular endothe

Comparative efficacy of vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) and mammalian target of rapamycin (mTOR) inhibitor as second-line therapy in patients with metastatic renal cell carcinoma after the failure of first-line VEGF TKI

✍ Kwonoh Park, Jae-Lyun Lee, Inkeun Park, Seongjoon Park, Yongcheol Ahn, Jin-Hee A 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 193 KB